While the biopharma industry faces compressive disruption that is threatening traditional approaches, all signs indicate that companies that embrace New Science are driving exceptional growth today and will continue to do so into the future.

New Science – which is described as an ever-evolving combination of science and health technology that is filling unmet need and raising the standard of care – includes new, ground-breaking solutions such as the development of software as a medical device (SaMD).

In this webinar, Accenture experts will explore the emergence of SaMD as a new class of medical device and discuss the potential challenges that biopharma companies face in the development of these solutions. From unique approaches to clinical trials, to navigating the regulatory hurdles, companies are innovating quickly to develop software solutions that could bring new, life-changing solutions to patients around the world.

Featured Speakers

Supriya Lagu

Digital Health Transformations Lead

Supriya has over 15 years of experience in leading cross functional matrixed teams to deliver technology based digital solutions in the medical device and pharma biotech industries. Supriya's work has been focused on expanding digital and innovative initiatives in support of Clinical Programs in various stages of clinical drug development and use of real-world evidence for the drug products on the market.

Andrew Greenberg

Global Digital Practice Lead

Andy has more than 20 years of experience developing and leading high-performance teams and launching technology-based and Internet of Things (IoT) products in the healthcare, life sciences, and wellness spaces. He combines an in-depth knowledge of behavioral research and the latest sensor, AI, and mobile advancements with an extensive network of executive insurance, wellness, and corporate contacts to help organizations make faster, better informed decisions and ultimately follow a quicker, sustainable path to success.


Register now for this webinar